Biomarkers are detectable molecules that can reflect specific physiological states of cells,
organs, and organisms and therefore be regarded as indicators for specific diseases. And …

Gastric cancer (GC) is the fifth most frequently diagnosed cancer worldwide and the third
leading cause of cancer-related death with an oncological origin. Despite its decline in …

Pre‐B‐cell leukaemia transcription factor (PBX) proteins are a subfamily of evolutionarily
conserved, atypical homeodomain transcription factors that belong to the superfamily of …

The burden of incidence rate and mortality of cancer is increasing rapidly, and the
development of precise intervention measures for cancer detection and treatment will help …

In recent years there has been a growth in the role of prevention in controlling the disease
burden. Increasing efforts have been conveyed in the screening implementation and public …

Tumor biomarkers, the substances which are produced by tumors or the body's responses to
tumors during tumorigenesis and progression, have been demonstrated to possess critical …

Simple Summary Early cancer detection is a challenge in treating cancer patients.
Remarkably, carcinomas of the breast, lung, liver, pancreas, ovary, and colon contribute to …

Multiple cancer types have limited targeted therapeutic options, in part due to incomplete
understanding of the molecular processes underlying tumorigenesis and significant intra …

Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive types of
squamous cell carcinoma and represents a significant proportion of esophageal cancer …

The desire for a cancer theranostic system with simultaneously accurate diagnosis and
efficient therapy is undeniably interminable. Heretofore, theranostic systems with simple …